| For: | Reshetnyak TM, Seredavkina NV, Satybaldyeva MA, Nasonov EL, Reshetnyak VI. Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome. World J Hepatol 2015; 7(19): 2229-2236 [PMID: 26380049 DOI: 10.4254/wjh.v7.i19.2229] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i19/2229.htm |
| Number | Citing Articles |
| 1 |
Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis. General Reanimatology 2019; 15(6) doi: 10.15360/1813-9779-2019-6-80-93
|
| 2 |
Virginie Dufrost, Jessie Risse, Tatiana Reshetnyak, Maria Satybaldyeva, Yao Du, Xin-Xin Yan, Stella Salta, Grigorios Gerotziafas, Zhi-Cheng Jing, Ismaël Elalamy, Denis Wahl, Stéphane Zuily. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmunity Reviews 2018; 17(10) doi: 10.1016/j.autrev.2018.04.009
|
| 3 |
Dante Pio Pallotta, Eugenio Franceschini, Maria Boe, Agnese Pratelli, Giovanni Monaco, Andrea De Sinno, Alessandro Granito. From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management. iLIVER 2025; 4(4) doi: 10.1016/j.iliver.2025.100197
|
| 4 |
Paulina Janiak, Żaneta Smoleńska, Monika Skotarczak, Zbigniew Zdrojewski. Celiac trunk thrombosis in a patient with antiphospholipid syndrome induced by median arcuate ligament compression: a case presentation and literature review. Rheumatology International 2023; 44(1) doi: 10.1007/s00296-023-05448-6
|
| 5 |
A. P. Panova, V. G. Avdeev, T. N. Krasnova, T. P. Rozina, E. P. Pavlikova, O. A. Georginova, A. L. Filatova, E. N. Borisov, P. I. Novikov. Liver involvement in patients with systemic lupus erythematosus. Rheumatology Science and Practice 2021; 59(2) doi: 10.47360/1995-4484-2021-164-172
|
| 6 |
Guido Finazzi, Walter Ageno. Direct oral anticoagulants in rare venous thrombosis. Internal and Emergency Medicine 2016; 11(2) doi: 10.1007/s11739-016-1398-6
|
| 7 |
Md. Asiful Islam, Fahmida Alam, Teguh H Sasongko, Azlan Husin, Sarimah Abdullah, Siew Hua Gan, Kah Keng Wong. Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD012198
|
| 8 |
Emily Lin, Charles Bratton, Minh-Tri Nguyen, Joshua Chung, Michael De Vera, Mina Rakoski. Combined coronary artery bypass graft and liver/kidney transplantation in a liver failure patient with acute on chronic kidney failure and antiphospholipid syndrome. American Journal of Transplantation 2022; 22(10) doi: 10.1111/ajt.17067
|
| 9 |
Jakub Rochoń, Piotr Kalinowski, Joanna Marczak, Krzysztof Gibiński, Michał Grąt. Inferior Vena Cava-Atrial Anastomosis in Liver Transplant Recipient with Inferior Vena Cava Occlusion: A Case Report and Literature Review. Journal of Clinical Medicine 2026; 15(1) doi: 10.3390/jcm15010384
|
| 10 |
Virginie Dufrost, Jessie Risse, Stéphane Zuily, Denis Wahl. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature. Current Rheumatology Reports 2016; 18(12) doi: 10.1007/s11926-016-0623-7
|
| 11 |
Jorge Sanchez-Redondo, Gerard Espinosa, David Varillas Delgado, Ricard Cervera. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis. Clinical Therapeutics 2019; 41(9) doi: 10.1016/j.clinthera.2019.06.015
|
| 12 |
R. Okeke, J. Lok, R. Wells, M. Wycoff, A. Engelhardt, J. Bettag, C. O’Leary, T. Hallcox, M. Nazzal, Ryszard Grenda. Catastrophic Antiphospholipid Syndrome after Orthotopic Liver Transplant. Case Reports in Transplantation 2022; 2022 doi: 10.1155/2022/6209300
|
| 13 |
Rachel C. Steckelberg, Zarah D. Antongiorgi, Randolph H. Steadman. Liver Transplantation in a Patient With Antiphospholipid Syndrome. A & A Case Reports 2017; 9(5) doi: 10.1213/XAA.0000000000000551
|
| 14 |
Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Vinicius Domingues, Roger Abramino Levy. New and upcoming treatments in antiphospholipid syndrome: A comprehensive review. Pharmacological Research 2018; 133 doi: 10.1016/j.phrs.2018.04.012
|
| 15 |
Andrew D. Santeusanio, Alan D. Weinberg, Sander S. Florman, Thomas D. Schiano. Safety of direct‐acting oral anticoagulants relative to warfarin in a matched cohort of liver transplant recipients. Clinical Transplantation 2020; 34(1) doi: 10.1111/ctr.13756
|
| 16 |
Shrinjaya B. Thapa, Gabriel Roman Souza, Mahati Paravathaneni, Sean Cohen, Turab Mohammed, Damian A. Laber. Direct Oral Anticoagulants in Budd‐Chiari Syndrome. European Journal of Haematology 2025; 114(3) doi: 10.1111/ejh.14363
|
| 17 |
Katherine T. Forkin, Douglas A. Colquhoun, Edward C. Nemergut, Julie L. Huffmyer. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesthesia & Analgesia 2018; 126(1) doi: 10.1213/ANE.0000000000002394
|
| 18 |
V. I. Reshetnyak, I. V. Maev, T. M. Reshetnyak, S. V. Zhuravel, V. M. Pisarev. Liver Diseases and the Hemostasis (Rewiew) Part 1. Non-Cholestatic Diseases of the Liver and Hemostasis. General Reanimatology 2019; 15(5) doi: 10.15360/1813-9779-2019-5-74-87
|